The lotus (Nelumbo nucifera) is a fresh-water plant that grows in semitropical climates. It is cultivated extensively in Asian countries, particularly in China. Besides its popularity as an ornamental flower, it is also used as an herbal medicine, mainly in China, Japan, and India, and it displays strong antipyretic, cooling, astringent, and demulcent properties. Lotus seed is widely used as a food in China. Lotus seed is rich in protein, amino acids, unsaturated fatty acids, and has adequate amounts of essential minerals such as potassium, calcium, magnesium, and iron, without heavy metal contamination. As a protein source, the crude protein of lotus seed is higher than parboiled rice (7.70%) and wheat (8.55%). Unlike legumes, lotus seed possesses adequate sulfuric amino acids (methionine + cysteine), comparable to the FAO/WHO and soybean reference patterns. The high content and high quality of protein in lotus seeds emphasizes their value as a vital source of nutrients…
Tag: <span>protein extraction</span>
For more than a decade, transgenic plants have been investigated as alternatives to microbial, mammalian cell, and transgenic animal systems for recombinant protein production. The main advantages of using plants as “bioreactors” are that the cost of upstream production (i.e. biomass creation) is low; plants do not carry viruses and other pathogens dangerous to humans such as human immunodeficiency virus (HIV), prions, hepatitis viruses and so on; and as eukaryotes, plants are capable of producing bioactive proteins. Numerous recombinant proteins have been expressed in various plant hosts, and some recombinant proteins are in various stages of clinical trials…
The use of plants as protein expression hosts for human therapeutic proteins is emerging as a safe and cost-effective alternative to microbial and mammalian cell culture. Pharmaceutical protein production is typically carried out in microbes and mammalian cell culture because of their high production potential and/or ability to produce complex eukaryotic proteins. However, immense costs are typically required for production facilities to support their growth. To offset these costs, companies usually build and expand a production facility over several years. In fact, it has been predicted that the demand for high-value pharmaceuticals produced by cell culture will quickly surpass the ability of pharmaceutical companies to produce them…